The changing paradigm of colorectal cancer therapy: the impact of vascular endothelial growth factor and epidermal growth factor and epidermal growth factor receptor inhibition. Introduction
Chase, J.L.
Pharmacotherapy 28(11 Pt 2): 17S
2008
ISSN/ISBN: 0277-0008
PMID: 18980547
DOI: 10.1592/phco.28.11-supp.17s
Accession: 056260031
PDF emailed within 0-6 h: $19.90
Related References
Garcia, B.; Neninger, E.; De la Torre, A.; Leonard, I.; Martinez, R.; Viada, C.; Gonzalez, G.; Mazorra, Z.; Lage, A.; Crombet, T. 2008: Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti-Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non -Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer Vaccine Clinical Cancer Research 14(3): 840-846García, B.; Neninger, E.; de la Torre, A.; Leonard, I.; Martínez, R.ío.; Viada, C.; González, G.; Mazorra, Z.; Lage, A.ín.; Crombet, T. 2008: Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(3): 840-846
Secades, P.; de Santa-María, I.és.S.; Merlo, A.; Suarez, C.; Chiara, M.ía.-D. 2015: In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy Head and Neck 37(8): 1150-1162
Marshall, J.L. 2009: Vascular Endothelial Growth Factor plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism? Journal of Oncology 2009: 937305
Goudar, R.K.; Shi, Q.; Hjelmeland, M.D.; Keir, S.T.; McLendon, R.E.; Wikstrand, C.J.; Reese, E.D.; Conrad, C.A.; Traxler, P.; Lane, H.A.; Reardon, D.A.; Cavenee, W.K.; Wang, X-Fan.; Bigner, D.D.; Friedman, H.S.; Rich, J.N. 2005: Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition Molecular Cancer Therapeutics 4(1): 101-112
Rydén, L.; Jirström, K.; Bendahl, P.är.-O.; Fernö, M.år.; Nordenskjöld, B.; Stål, O.; Thorstenson, S.; Jönsson, P.-E.; Landberg, G.ör. 2005: Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(21): 4695-4704
Vincenzi, B.; Santini, D.; Tonini, G. 2006: New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24(12): 1957; author reply 1957-8
Chang, H.-C.; Chen, Y.-M.; Tseng, C.-C.; Huang, K.-T.; Wang, C.-C.; Chen, Y.-C.; Lai, C.-H.; Fang, W.-F.; Kao, H.-C.; Lin, M.-C. 2017: Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 39(3): 1010428317695939
Wang, J-Xiang.; Wu, H-Long.; Zhu, M.; Zhou, R. 2020: Role of Anti-Epidermal Growth Factor Receptor Therapy Compared with Anti-Vascular Endothelial Growth Factor Therapy for Metastatic Colorectal Cancer: an Update Meta-Analysis of Randomized Clinical Trials Pathology Oncology Research: Por 26(1): 159-166
Khattak, M.A.; Martin, H.; Davidson, A.; Phillips, M. 2015: Role of first-line anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy in advanced colorectal cancer: a meta-analysis of randomized clinical trials Clinical Colorectal Cancer 14(2): 81-90
Kehoe, S.M.; Ma, C.; Rosales, N.; Rao, T.; Dupont, J.; Spriggs, D.R. 2016: Effect of combination inhibition of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGF-R) on ovarian cancer cell lines Journal of Clinical Oncology 24(18_Suppl): 13112-13112
Pakkala, S.; Ramalingam, S.S. 2009: Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy Clinical Lung Cancer 10(Suppl 1): S17-S23
Rautenberg, T.; Siebert, U.; Arnold, D.; Bennouna, J.; Kubicka, S.; Walzer, S.; Ngoh, C. 2014: Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer Journal of Medical Economics 17(2): 99-110
Sasaki, T.; Kitadai, Y.; Nakamura, T.; Kim, J.-S.; Tsan, R.Z.; Kuwai, T.; Langley, R.R.; Fan, D.; Kim, S.-J.; Fidler, I.J. 2007: Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice Neoplasia 9(12): 1066-1077
Nan, J.; Liu, Q.; Ding, Y.; Zhang, Z.; Gao, A.C.; Zhou, Q. 2009: Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non-small Cell Lung Cancer Therapy. Zhongguo Fei Ai Za Zhi 12(12): 1316-1324